Dr. Felipe Cadavid, MD

Dr. Cadavid practices at Halifax Health Medical Center of Daytona Beach in Daytona Beach, Florida, part of Halifax Health District.

Dr. Cadavid's NPI, 1669890299, was assigned on April 1, 2014. Dr. Cadavid graduated from Florida State University College Of Medicine in 2014. Dr. Cadavid holds Florida license ME157353.

Dr. Cadavid's primary practice is Halifax Health Medical Center of Daytona Beach, at 303 N Clyde Morris Blvd, Daytona Beach, FL 32114 in Volusia County. The practice phone is (386) 254-4000.

Dr. Cadavid's primary practice is Halifax Health Medical Center of Daytona Beach in Daytona Beach, Florida, part of Halifax Health District. Dr. Cadavid is also affiliated with UF Health Shands Hospital. The medical group on file is UF Health Physicians. Dmand AI also links Dr. Cadavid to 1 more behavioral health center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cadavid practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Cadavid's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Cadavid is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Cadavid's licenses on file in 2 states: Florida and Alabama.

Dmand AI lists amputation, aortic atherosclerois, arterial blot clot /embolism, blood vessel access for dialysis, carotid revascularization, deep vein thrombosis (DVT), leg revascularization and peripheral vascular disease among the conditions Dr. Cadavid treats.

CMS data shows 457 Medicare services from Dr. Cadavid across 12 procedure codes in 2024, for 296 Medicare patients. Medicare paid $37,276 for them.

CMS counts 296 Medicare patients who saw Dr. Cadavid in 2024. The largest group is 65 to 74, with 121 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cadavid's median patient age at 74, with 49% women.

In 2024, Dr. Cadavid wrote 51 Medicare Part D claims for 32 patients. 86% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $220 in total drug cost. In 2019, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Cadavid for performance year 2024, reported individually. Dr. Cadavid accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Cadavid in 2021. Dr. Cadavid's most frequent co-authors are Martin R. Back, MD, Robert Joseph Feezor, MD and Thomas S. Huber, MD, PhD.

CMS Open Payments shows 47 general payments to Dr. Cadavid from 18 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. W. L. Gore & Associates, Inc. paid the most, $587.

Dr. Cadavid graduated from Florida State University College Of Medicine in 2014.

Dr. Cadavid is in network with 16 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.